A hybrid optimization method to design a sustainable resilient supply chain in a perishable food industry.

To integrate the location, inventory, and routing (LIR) problems arising in designing a resilient sustainable perishable food supply network (RSPFSN), a bi-objective optimization model is developed. To improve the resiliency and sustainability of the RSPFSN, a dynamic pricing strategy is used to cope with the disrupting events, along with minimizing the total cost and CO emission of the whole network. One of the important features of the proposed model is taking into account the effects of route disruptions and traffic conditions on the deterioration of products.

A hybrid decision-making framework to manage occupational stress in project-based organizations.

According to recent studies in the field of human resource management (HRM), especially in project-based organizations (PBOs), stress is recognized as a factor that has a paramount significance on the performance of staff. Previous studies in organizational stress management have mainly focused on identifying job stressors and their effects on organizations. Contrary to the previous studies, this paper aims to propose a comprehensive decision-support system that includes identifying stressors, assessing organizational stress levels, and providing solutions to improve the performance of the organization.

Designing a sustainable closed-loop pharmaceutical supply chain in a competitive market considering demand uncertainty, manufacturer's brand and waste management.

Unlabelled: Pharmaceutical supply chain (PSC) is one of the most important healthcare supply chains and the recent pandemic (COVID-19) has completely proved it. Also, the environmental and social impacts of PSCs are undeniable due to the daily entrance of a large amount of pharmaceutical waste into the environment. However, studies on closed-loop PSCs (CLPSC) are rarely considered real-world requirements such as competition among diverse brands of manufacturers, the dependency of customers' demand on products' price and quality, and diverse reverse flows of end-of-life medicines.